These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

135 related items for PubMed ID: 12533688

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Early Treatment of Coxsackievirus B3-Infected Animals With Soluble Coxsackievirus-Adenovirus Receptor Inhibits Development of Chronic Coxsackievirus B3 Cardiomyopathy.
    Pinkert S, Dieringer B, Klopfleisch R, Savvatis K, Van Linthout S, Pryshliak M, Tschöpe C, Klingel K, Kurreck J, Beling A, Fechner H.
    Circ Heart Fail; 2019 Nov; 12(11):e005250. PubMed ID: 31718319
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Protease-activated receptor-2 regulates the innate immune response to viral infection in a coxsackievirus B3-induced myocarditis.
    Weithauser A, Bobbert P, Antoniak S, Böhm A, Rauch BH, Klingel K, Savvatis K, Kroemer HK, Tschope C, Stroux A, Zeichhardt H, Poller W, Mackman N, Schultheiss HP, Rauch U.
    J Am Coll Cardiol; 2013 Nov 05; 62(19):1737-45. PubMed ID: 23871888
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Virus receptor trap neutralizes coxsackievirus in experimental murine viral myocarditis.
    Lim BK, Choi JH, Nam JH, Gil CO, Shin JO, Yun SH, Kim DK, Jeon ES.
    Cardiovasc Res; 2006 Aug 01; 71(3):517-26. PubMed ID: 16806133
    [Abstract] [Full Text] [Related]

  • 10. Lithium chloride confers protection against viral myocarditis via suppression of coxsackievirus B3 virus replication.
    Zhao Y, Yan K, Wang Y, Cai J, Wei L, Li S, Xu W, Li M.
    Microb Pathog; 2020 Jul 01; 144():104169. PubMed ID: 32205210
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Cardiovirulent coxsackieviruses and the decay-accelerating factor (CD55) receptor.
    Martino TA, Petric M, Brown M, Aitken K, Gauntt CJ, Richardson CD, Chow LH, Liu PP.
    Virology; 1998 May 10; 244(2):302-14. PubMed ID: 9601501
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Decay-accelerating factor (CD55) promotes CD1d expression and Vgamma4+ T-cell activation in coxsackievirus B3-induced myocarditis.
    Huber S, Song WC, Sartini D.
    Viral Immunol; 2006 May 10; 19(2):156-66. PubMed ID: 16817758
    [Abstract] [Full Text] [Related]

  • 15. Genomic detection of enteroviruses in the myocardium--studies on animal hearts with coxsackievirus B3 myocarditis and endomyocardial biopsies from patients with myocarditis and dilated cardiomyopathy.
    Koide H, Kitaura Y, Deguchi H, Ukimura A, Kawamura K, Hirai K.
    Jpn Circ J; 1992 Oct 10; 56(10):1081-93. PubMed ID: 1331557
    [Abstract] [Full Text] [Related]

  • 16. A decay-accelerating factor-binding strain of coxsackievirus B3 requires the coxsackievirus-adenovirus receptor protein to mediate lytic infection of rhabdomyosarcoma cells.
    Shafren DR, Williams DT, Barry RD.
    J Virol; 1997 Dec 10; 71(12):9844-8. PubMed ID: 9371658
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.